Rocket Lab SEC Filings

Form 144 filed by Rocket Lab officer Adam Spice discloses intent to sell 68,254 common shares on 9/16/2025. Shares originate from vesting of 114,845 RSUs on 9/15/2025 as compensation, with sale covering tax obligations. This routine insider liquidity event shows no prior 3-month sales.

This 424B5 is a prospectus supplement for an at-the-market offering of up to $750M common stock via sales agents. It terminates a prior $500M agreement after $396.6M in sales and allows flexible issuances at market prices with up to 3% commissions. Relevant to investors as it signals potential dilution to fund growth and acquisitions.

Rocket Lab entered into an ATM Equity Offering Sales Agreement on September 15, 2025, enabling sales of up to $750 million in common stock through agents like BofA Securities and Cantor Fitzgerald. The company terminated its prior ATM agreement from March 11, 2025. No shares are obligated to be sold; proceeds would fund general corporate purposes.

This Form 144 discloses Peter Beck, Rocket Lab's CEO, proposing to sell 2,500,000 Class A common shares with an aggregate market value of $135.1 million on or around September 15, 2025. The shares originate from the 2021 business combination via preferred stock conversion, with no prior sales in the past three months. Investors should note this planned insider sale complies with Rule 10b5-1, adopted June 13, 2025, reducing potential insider trading concerns.

This Schedule 13D Amendment No. 7 discloses pro rata distributions of 8 million RKLB shares by Khosla Ventures V, L.P. from July 23 to September 2, 2025, triggering the filing. The Khosla group beneficially owns 43,433,056 shares (9.0%), primarily via VK Services, LLC. Investors should note the passive investment stance with registration rights intact.

Rocket Lab's Compensation Committee adopted a Senior Executive Cash Incentive Bonus Plan on August 25, 2025, for cash bonuses tied to corporate and individual performance. At the August 27 annual meeting, stockholders elected three Class I directors, ratified Deloitte as auditors, approved executive comp advisory vote, but rejected amendment to eliminate subsidiary pass-through voting (failed 66-2/3% threshold). No quantifiable financial impact.

Alexander R. Slusky, a Director at Rocket Lab USA Inc., acquired 3,960 restricted stock units (RSUs) on 08/27/2025 at $0.00 per share under the company's Non-Employee Director Compensation Policy. This standard equity grant vests on the next annual meeting or one-year anniversary. The transaction is neutral, representing routine director compensation rather than discretionary buying.

Edward H. Frank, Director at Rocket Lab USA, was granted 3,960 restricted stock units (RSUs) on 08/27/2025 at $0.00 per share, increasing direct holdings to 150,004 shares. This is standard non-employee director compensation. Neutral signal as routine equity grant.

Jon A. Olson, a Director at Rocket Lab USA Inc., acquired 3,960 restricted stock units (RSUs) on 08/27/2025 at $0.00 per share. This is standard non-employee director compensation under the company's policy. The signal is neutral, representing routine equity alignment rather than discretionary buying.

Kenneth R. Possenriede, Director at Rocket Lab USA (RKLB), acquired 3,960 restricted stock units (RSUs) on 08/27/2025 at $0.00 per share. This standard compensation grant increases his direct holdings to 94,178 shares. Neutral signal as routine director equity award.